Related Parties (Details) - P3 Health Partners Inc. - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | 11 Months Ended | 12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Dec. 02, 2021 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Related Party Transaction [Line Items] | |||||||||||
| Financial Designation, Predecessor and Successor [Fixed List] | Successor | Successor | Successor | Predecessor | Predecessor | Successor | Predecessor | Predecessor | Predecessor | Predecessor | |
| Balance at Beginning of Year | $ 23,639,987 | $ 19,354,258 | $ 25,882,296 | $ 19,354,258 | $ 19,354,258 | $ 19,354,258 | $ 14,400,045 | ||||
| Advanced During Period | 470,165 | 2,223,912 | 2,862,350 | 3,772,573 | |||||||
| Interest Accrued During period | 679 | 437,236 | 1,423,379 | 1,181,640 | |||||||
| Balance at End of Year | $ 25,882,296 | 25,882,296 | $ 28,543,444 | 28,543,444 | 23,639,987 | 25,882,296 | 19,354,258 | $ 14,400,045 | |||
| Previously Reported [Member] | |||||||||||
| Related Party Transaction [Line Items] | |||||||||||
| Balance at Beginning of Year | 24,110,831 | ||||||||||
| Balance at End of Year | $ 24,110,831 | 24,110,831 | 24,110,831 | ||||||||
| Atrio | |||||||||||
| Related Party Transaction [Line Items] | |||||||||||
| Revenue Earned from Capitation | 11,483,345 | 42,935,126 | 87,599,807 | 142,904,723 | 146,469,571 | ||||||
| Management Fees | 180,768 | 572,250 | 1,145,634 | 2,022,076 | 2,230,984 | ||||||
| Claims Paid | $ 14,684,345 | $ 50,247,316 | $ 97,505,664 | $ 146,216,160 | 148,905,784 | ||||||
| P3 NV and KWA | |||||||||||
| Related Party Transaction [Line Items] | |||||||||||
| Advanced During Period | $ 0 | $ 0 | |||||||||
| X | ||||||||||
- Definition Amount of management fees with related party. No definition available.
|
| X | ||||||||||
- Definition Amount of claims paid to related party. No definition available.
|
| X | ||||||||||
- Definition Indicates designation of financial information when substantially all business or separately identifiable line of business transfers from one entity to another entity. Acceptable values are "Predecessor" and "Successor". Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition For an unclassified balance sheet, reflects the carrying amount of unpaid loan amounts due from related parties at the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Reflects the amount of new advances made to related parties in the form of loan and lease receivables. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in loans and leases receivable due from related parties. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|